Most linked-to pages

Jump to navigation Jump to search

Showing below up to 50 results in range #11,801 to #11,850.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Wolfson B, et al. World J. Biol. Chem. (2015) cited as Ref 483 in DOI: 10.1038/s41392-020-0110-5 (Q9746)‏‎ (2 links)
  2. Huang C, et al, Lancet (2020), cited as Ref 33 in DOI: 10.1186/s13054-020-02882-x (Q10664)‏‎ (2 links)
  3. Song Z, et al. PLoS ONE (2011) cited as Ref 259 in DOI: 10.1038/s41392-020-0110-5 (Q9522)‏‎ (2 links)
  4. Saygin C, et al. Cell Stem Cell (2019) cited as Ref 628 in DOI: 10.1038/s41392-020-0110-5 (Q9891)‏‎ (2 links)
  5. JK Scott kickoff for 65 yds for a touchback (9-30-17e) (Q2563)‏‎ (2 links)
  6. CXADR Ig-like cell adhesion molecule (gene) (Q10976)‏‎ (2 links)
  7. Yibing H, et al. PLoS ONE (2015) cited as Ref 491 in DOI: 10.1038/s41392-020-0110-5 (Q9754)‏‎ (2 links)
  8. Ding Y, et al, J Pathol (2004), cited as Ref 41 in DOI: 10.1186/s13054-020-02882-x (Q10672)‏‎ (2 links)
  9. Kim Bo Ram, et al. Cell Death & Differentiation (2019) cited as Ref 267 in DOI: 10.1038/s41392-020-0110-5 (Q9530)‏‎ (2 links)
  10. Meindl-Beinker NM, et al. BMC Cancer (2019) cited as Ref 636 in DOI: 10.1038/s41392-020-0110-5 (Q9899)‏‎ (2 links)
  11. Abdel AMT, et al. J. Exp. Clin. Cancer Res. (2011) cited as Ref 499 in DOI: 10.1038/s41392-020-0110-5 (Q9762)‏‎ (2 links)
  12. Khan S, et al, J Hosp Infect (2020), cited as Ref 49 in DOI: 10.1186/s13054-020-02882-x (Q10680)‏‎ (2 links)
  13. Hoesel B, et al. Mol. Cancer (2013) cited as Ref 275 in DOI: 10.1038/s41392-020-0110-5 (Q9538)‏‎ (2 links)
  14. Rich JN, et al. Medicine (2016) cited as Ref 644 in DOI: 10.1038/s41392-020-0110-5 (Q9907)‏‎ (2 links)
  15. Azithromycin (chemical - MeSH descriptor) (Q10834)‏‎ (2 links)
  16. Ma YC, et al. PLoS ONE (2012) cited as Ref 507 in DOI: 10.1038/s41392-020-0110-5 (Q9770)‏‎ (2 links)
  17. Netland J, et al, J Virol (2008), cited as Ref 57 in DOI: 10.1186/s13054-020-02882-x (Q10688)‏‎ (2 links)
  18. Shi S, et al, JAMA Cardiol (2020), cited as Ref 21 in DOI:10.14218/ERHM.2020.00023 (Q10796)‏‎ (2 links)
  19. Taniguchi K, et al. Nat. Rev. Immunol. (2018) cited as Ref 283 in DOI: 10.1038/s41392-020-0110-5 (Q9546)‏‎ (2 links)
  20. Takeishi S, et al. Cancer Sci. (2016) cited as Ref 652 in DOI: 10.1038/s41392-020-0110-5 (Q9915)‏‎ (2 links)
  21. Schrader J, et al. Hepatology (2011) cited as Ref 515 in DOI: 10.1038/s41392-020-0110-5 (Q9778)‏‎ (2 links)
  22. Azithromycin (chemical - MeSH descriptor)‏‎ (2 links)
  23. Zhou J, et al, J Immunol (2003), cited as Ref 65 in DOI: 10.1186/s13054-020-02882-x (Q10696)‏‎ (2 links)
  24. Vazquez-Santillan K, et al. Sci. Rep. (2016) cited as Ref 291 in DOI: 10.1038/s41392-020-0110-5 (Q9554)‏‎ (2 links)
  25. Lu HH, et al. Nat. Cell Biol. (2014) cited as Ref 660 in DOI: 10.1038/s41392-020-0110-5 (Q9923)‏‎ (2 links)
  26. Brent Cimaglia kickoff for 56 yds Henry Ruggs III return for 15 yds to the Alab 24 (10-21-17)‏‎ (2 links)
  27. Pete H, et al. Proc. Natl Acad. Sci. USA (2009) cited as Ref 523 in DOI: 10.1038/s41392-020-0110-5 (Q9786)‏‎ (2 links)
  28. Pandharipande PP, et al, N Engl J Med (2013), cited as Ref 73 in DOI: 10.1186/s13054-020-02882-x (Q10704)‏‎ (2 links)
  29. Liu S, et al. Oncotarget (2017) cited as Ref 299 in DOI: 10.1038/s41392-020-0110-5 (Q9562)‏‎ (2 links)
  30. Yin AH, et al. Blood (1997) cited as Ref 668 in DOI: 10.1038/s41392-020-0110-5 (Q9931)‏‎ (2 links)
  31. JK Scott kickoff for 63 yds Jamauri Wakefield return for 22 yds to the Vandy 24 (9/23/17)‏‎ (2 links)
  32. Rana S, et al. Neoplasia (2013) cited as Ref 531 in DOI: 10.1038/s41392-020-0110-5 (Q9794)‏‎ (2 links)
  33. Meng L, et al, Anesthesiology (2020), cited as Ref 81 in DOI: 10.1186/s13054-020-02882-x (Q10712)‏‎ (2 links)
  34. Wuhan Municipal Health Commission, et al, Wuhan Municipal Health Commission (2020) cited as Ref 1 in DOI: 10.3201/eid2605.200146 (Q11207)‏‎ (2 links)
  35. Haan C, et al. Biochem. Pharmacol. (2006) cited as Ref 307 in DOI: 10.1038/s41392-020-0110-5 (Q9570)‏‎ (2 links)
  36. Bae KM, et al. Am. J. Cancer Res. (2011) cited as Ref 676 in DOI: 10.1038/s41392-020-0110-5 (Q9939)‏‎ (2 links)
  37. JK Scott kickoff for 65 yds for a touchback (9/23/17d)‏‎ (2 links)
  38. Ye J, et al. Tumor Biol. (2014) cited as Ref 539 in DOI: 10.1038/s41392-020-0110-5 (Q9802)‏‎ (2 links)
  39. Chan JF-W, et al, Lancet (2020) cited as Ref 9 in DOI: 10.3201/eid2605.200146 (Q11215)‏‎ (2 links)
  40. Kiladjian JJ, et al. Hematol. Am. Soc. Hematol. Educ. Program (2012) cited as Ref 315 in DOI: 10.1038/s41392-020-0110-5 (Q9578)‏‎ (2 links)
  41. Bao SD, et al. Cancer Res. (2008) cited as Ref 684 in DOI: 10.1038/s41392-020-0110-5 (Q9947)‏‎ (2 links)
  42. Tian X, et al. Hum. Vaccin. Immunother. (2013) cited as Ref 547 in DOI: 10.1038/s41392-020-0110-5 (Q9810)‏‎ (2 links)
  43. Kanno H, et al. Int. J. Oncol. (2013) cited as Ref 323 in DOI: 10.1038/s41392-020-0110-5 (Q9586)‏‎ (2 links)
  44. Fujikuni N, et al. Cancer Sci. (2014) cited as Ref 692 in DOI: 10.1038/s41392-020-0110-5 (Q9955)‏‎ (2 links)
  45. Riechelmann H, et al. Oral. Oncol. (2008) cited as Ref 555 in DOI: 10.1038/s41392-020-0110-5 (Q9818)‏‎ (2 links)
  46. Mullins E, et al, Ultrasound Obstet. Gynecol. (2020), cited as Ref 3 in DOI: 10.1016/j.jcv.2020.104372 (Q10450)‏‎ (2 links)
  47. Ruan Z, et al. Cancer Manag. Res. (2019) cited as Ref 331 in DOI: 10.1038/s41392-020-0110-5 (Q9594)‏‎ (2 links)
  48. Fan W, et al. Oncol. Lett. (2019) cited as Ref 700 in DOI: 10.1038/s41392-020-0110-5 (Q9963)‏‎ (2 links)
  49. Neu N, et al, Clin. Perinatol. (2015), cited as Ref 11 in DOI: 10.1016/j.jcv.2020.104372 (Q10458)‏‎ (2 links)
  50. Frolik CA, et al. Proc. Natl Acad. Sci. USA (1983) cited as Ref 339 in DOI: 10.1038/s41392-020-0110-5 (Q9602)‏‎ (2 links)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)